Antibiotics - Global Trends

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW AND OUTLOOK
Antibiotic Resistance and Generic Competition to Impact Long Term Growth
3.MARKET DYNAMICS
Anti-Bacterials Segment Drives Global Anti-Infectives Market
Antibiotic Resistance – A Primary Growth Inhibitor
Antibiotic-Resistant Bacteria by Type
Patent Expiries Commoditize Antibiotics
Patent Expiries of Leading Drugs in the Current and Future
Anti-MRSA Antibiotics Find Their Way
Key Antibiotics in Pipeline
4.COMPETITION
Highly Competitive Market
GlaxoSmithKline – The Undisputed Leader of Penicillin Market
GlaxoSmithKline Leads Cephalosporin Market
Pfizer Dominates Macrolides Market
Levaquin/Tavanic – The Most Preferred Quinolone Antibiotic
Merck Rules Carbapenems Market
5.PRODUCT FACTS
Penicillin
Cephalosporins
Macrolides
Quinolones
Carbapenems
Other Antibiotics
Aminoglycosides
Tetracyclines
Sulfonamides
Mupirocin
Glycopeptides
Synercid
Oxazolidinones
Linezolid
6.RESEARCH FINDINGS
Cephalosporins Effective when Compared to Penicillin
FDA Bans Baytril Antibiotic for Chickens
Erythromycin Along with Some Specific Drugs Increase Risk of Sudden Death
Rise in Usage of Quinolones for Urinary Tract Infections Leads to Drug Resistance
7.CORPORATE DEVELOPMENTS
3i to Buy Alpharma Unit
NCPC to Acquire Stake in DSM’s Antibiotics Division
ULL Establishes New Antibiotics Unit in Himachal Pradesh
Biocat to Expand Presence in the Indian Market
PRWT Acquires Cherokee Chemical Unit from Merck
CSPC Joins Hands with Indonesian Firms
MIT Scientists Develop a New Antibiotic, Rhodostreptomycin
Watson Pharma Introduces Biaxin XL’s Generic Version
MiddleBrook Obtains NDA Approval for MOXATAG™
Nisshin-Kyorin to Merge with Kyorin Pharmaceutical
Schering-Plough Acquires Organon BioSciences
GSK & Anacor Partner for Boron Chemistry- Based Antibiotics and Antivirals
Iroko Bags Canadian Rights to Vancocin®
Cubist Licenses CUBICIN Rights to Merck
Sagent Partners with Astral to Develop Injectable Antibiotics
MR Healthcare to Manufacture New Antibiotics & Medicines
Livzon Synthetic to Acquire Antibiotic Intermediate from Jiaozuo
C&O Pharmaceutical to Distribute Meiact in China
Bioton Signs Deal to Market Antibiotics in Russia
Toyama Gains Marketing Approval for Geninax® in Japan
Forest Laboratories Acquires Cerexa
Oscient Modifies Licensing Agreement With LG Life Sciences
Orchid Sign Licensing & Distribution Pact With Actavis
Forest Laboratories Revokes Partnership With Replidyne
SRI and Blanca Collaborate To Develop & Test Carbacephem
AstraZeneca To Expand Research Center for Antibiotics
Jade Pharmaceutical Begins Levofloxacin’s Production in China
Reyoung To Start Antibiotic Production at New Facility
Toyama Begins T-705 Clinical Trials
SmPC For Sanofi-Aventis’ Ketek® Updated
Lupin Receives Approval for Cefpodoxime Proxetil Antibiotic Tablets in France
Antibiotice Plans To Infuse Funds for Antibiotics Production
UAE Approves Pfizer’s Zithromax SD
Toyama Launches New Garenoxacin Quinolone Antibiotic
Wockhardt to Introduce Cefprozil in the US
MSD India Launches Invanza in India
Orchid Chemicals to Introduce Three New Drugs in the US
DUSA Pharmaceuticals Releases ClindaReach™
Mylan Releases Cipro’s Generic Version
Macrolide Antibiotic Developed in the US
University of Michigan Devises NMR Spectroscopy For Antibiotics
Glycopeptide-Cephalosporin Antibiotics Developed in the US
Neosil Tests NEO 101 Antibiotic
New Antibiotic Developed By Canadian Inventors
Abbott Canada Releases FACTIVE® Antibiotic Tablets In Canada
Penicillin Binding Protein Found In Japan
Venus Remedies Releases Mucomelt-Forte
J&JPRD Seeks FDA Approval for Doripenem Antibiotic
J&JPRD Seeks FDA Approval for Investigational Antibiotic,Ceftobiprole
GSK Receives Approval for ALTARGO® in Europe
APL Receives FDA Approval for Cefpodoxime Proxetil
Cubist Receives Approval to Market CUBICIN in Canada
Cubist Obtains Approval to Market CUBICIN for Added Indications in EU
Cubist Gains Approval for CUBICIN in Taiwan and South Korea
Cethromycin Achieves FDA’s Orphan Drug Designation
8.MAJOR PLAYERS
Abbott Laboratories (USA)
Bayer HealthCare AG (Germany)
Bristol-Myers Squibb Co. (USA)
Cubist Pharmaceuticals, Inc. (USA)
Daiichi Sankyo Company, Limited (Japan)
Eli Lilly and Co. (USA)
GlaxoSmithKline Plc (UK)
Johnson & Johnson (USA)
Kyorin Pharmaceutical Co., Ltd. (Japan)
LG Life Sciences Limited (Korea)
MiddleBrook™ Pharmaceuticals, Inc. (USA)
Novartis AG (Switzerland)
Pfizer Inc. (USA)
Pliva d.d. (Croatia)
Roche (Switzerland)
Sanofi-Aventis SA (France)
Takeda Pharmaceutical Company, Ltd. (Japan)
Toyama Chemical Co., Ltd. (Japan)
Wyeth Pharmaceuticals, Inc. (USA)
9.GLOBAL MARKET ANALYTICS
10.THE UNITED STATES
Competition
11.CANADA
12.JAPAN
13.EUROPE
a.France
b.Germany
c.Italy
d.The United Kingdom
e.Spain
f.Rest of Europe
14.ASIA-PACIFIC
India
Rising Prices of Penicillin G to Affect Antibiotics Production
15.REST OF WORLD
Exhibits
Table 1: Percentage Breakdown of Leading Antibiotics Manufacturer Value Sales in the World -
Table 2: Percentage Breakdown of Leading Antibiotics Manufacturers within Penicillin Class in the World -
Table 3: Percentage Breakdown of Leading Antibiotics Manufacturers within Cephalosporin Class in the World -
Table 4: Percentage Breakdown of Leading Antibiotics Manufacturers within Macrolide Class in the World -
Table 5: Percentage Breakdown of Leading Antibiotics Manufacturers within Quinolone Class in the World -
Table 6: Percentage Breakdown of Leading Antibiotics Manufacturers within Carbapenem Class in the World –
Table 7: Global Antibiotics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Antibiotics Market by Region for the Years 2008 & 2009
Table 9: Global Penicillin Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Penicillin Market by Region for the Years 2008 & 2009
Table 11: Global Cephalosporin Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Cephalosporin Market by Region for the Years 2008 & 2009
Table 13: Global Macrolide Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown of Global Macrolide Market by Region for the Years 2008 & 2009
Table 15: Global Quinolones Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 16: Percentage Breakdown of Global Quinolones Market by Region for the Years 2008 & 2009
Table 17: Global Carbapenems Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 18: Percentage Breakdown of Global Carbapenems Market by Region for the Years 2008 & 2009
Table 19: Global Other Antibiotics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 20: Percentage Breakdown of Global Other Antibiotics Market by Region for the Years 2008 & 2009
Table 21: Percentage Breakdown of Leading Antibiotics Manufacturer Value Sales in the US -
Table 22: Antibiotics Market by Segment in the US: 2007-2015 (Sales in US$ Million)
Table 23: Percentage Breakdown of Antibiotics Market by Segment in the US for the Years 2008 & 2009
Table 24: Antibiotics Market by Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Antibiotics Market by Segment in Canada for the Years 2008 & 2009
Table 26: Antibiotics Market by Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown of Antibiotics Market by Segment in Japan for the Years 2008 & 2009
Table 28: Antibiotics Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown of Antibiotics Market by Region in Europe for the Years 2008 & 2009
Table 30: Antibiotics Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 31: Percentage Breakdown of Antibiotics Market by Segment in Europe for the Years 2008 & 2009
Table 32: Antibiotics Market by Segment in France: 2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Antibiotics Market by Segment in France for the Years 2008 & 2009
Table 34: Antibiotics Market by Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown of Antibiotics Market by Segment in Germany for the Years 2008 & 2009
Table 36: Antibiotics Market by Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Antibiotics Market by Segment in Italy for the Years 2008 & 2009
Table 38: Antibiotics Market by Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown of Antibiotics Market by Segment in the UK for the Years 2008 & 2009
Table 40: Antibiotics Market by Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 41: Percentage Breakdown of Antibiotics Market by Segment in Spain for the Years 2008 & 2009
Table 42: Antibiotics Market by Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown of Antibiotics Market by Segment in Rest of Europe for the Years 2008 & 2009
Table 44: Antibiotics Market by Segment in Asia Pacific: 2007-2015 (Sales in US$ Million)
Table 45: Percentage Breakdown of Antibiotics Market by Segment in Asia Pacific for the Years 2008 & 2009
Table 46: Antibiotics Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 47: Percentage Breakdown of Antibiotics Market by Segment in Rest of World for the Years 2008 & 2009
Companies Profiled